Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- fever
- symptoms of meningitis
- signs of meningitis
- symptoms of sepsis
- signs of sepsis
- symptoms of pneumonia
- signs of pneumonia
- symptoms of urinary tract infection
- signs of urinary tract infection
- symptoms of cellulitis
- signs of cellulitis
- symptoms of septic arthritis
- signs of septic arthritis
- symptoms of conjunctivitis
- symptoms of sinusitis
- signs of sinusitis
- symptoms of otitis media
- signs of otitis media
- symptoms of endometritis
- signs of endometritis
- signs of chorioamnionitis
Otros factores de diagnóstico
- nonspecific signs of infection in neonate
- nonspecific signs of infection in older patients
- symptoms of intra-abdominal infection
- signs of intra-abdominal infection
- midgestation abortion or preterm labor
Factores de riesgo
- 0 to 7 days of age
- maternal fever during labor
- premature rupture of membranes (PROM)
- previous baby with GBS disease
- maternal GBS colonization
- GBS bacteriuria during pregnancy
- preterm delivery (<37 weeks)
- low birth weight (<2500 g)
- deficient maternal-specific IgG at term
- twin sibling with GBS disease
- maternal age <20 years
- chorioamnionitis
- age >60 years
- pregnancy
- multiparity
- diabetes
- obesity
- advanced hepatic disease
- renal disease
- presence of central venous catheter
- urologic disorders
- break in skin integrity or skin ulcers
- neurologic disease
- immunosuppression
- nursing-home resident
- black or Hispanic race
- malignancy
- obstetric manipulation
- presence of urinary catheter
- HIV infection
- trauma
- asthma
- consumption of placenta capsules
Pruebas diagnósticas
Primeiras investigações a serem solicitadas
- CBC
- BUN
- serum electrolytes
- serum glucose
- coagulation studies
- LFTs
- C-reactive protein (CRP)
- blood culture
- cerebrospinal fluid (CSF) Gram stain
- CSF culture
- CSF cell count and differential
- CSF glucose and protein
- antigen detection in CSF
- Gram stain and culture of other sterile body fluids
- chest x-ray
- plain joint and/or bone x-ray
- CT head
Investigações a serem consideradas
- echocardiography
- MRI
Algoritmo de tratamento
early- or late-onset confirmed GBS neonatal infection (0-89 days of age)
infants and children
adults: nonpregnant
adults: pregnant and postpartum
Colaboradores
Autores
Brendan Healy, MBChB, BSc (Hons), MRCP, FRCPath
Consultant in Microbiology and Infectious Diseases
University Hospital of Wales
Cardiff
UK
Declarações
BH has received honorarium and has been reimbursed for attending conferences from AbbVie (hepatitis C), Gilead Sciences (hepatitis C), Bristol Myers Squibb (hepatitis C), and Tillotts Pharma (fidaxomicin). BH declares that he has no competing interests in relation to the work carried out for this topic review, Group B streptococcus.
Agradecimentos
Dr Brendan Healy would like to gratefully acknowledge Dr Susannah Froude and Dr Harriet Hughes, previous contributors to this topic. We would also like to gratefully acknowledge Dr Benjamin D. Lorenz for his contributions to this topic.
Declarações
SF declares that she has no competing interests. HH declares that she has received funds from Gilead and Biocomposites related to conference registration, travel, accommodation, and speaker fees.
Revisores
William A. Petri, Jr, MD, PhD, FACP
Chief and Professor of Medicine
Division of Infectious Diseases and International Health
University of Virginia Health System
Charlottesville
VA
Declarações
WAP declares that he has no competing interests.
James R. Hanley, MD, FAAP
Attending Physician
Pediatric Emergency Medicine
Ochsner Foundation Hospital
New Orleans
LA
Declarações
JRH declares that he has ownership of a limited amount of stock in various pharmaceutical companies, although no significant amounts of any company.
Kirsty Le Doare, BA, MBBS, MSc, PhD, FRCPCH
Professor of Vaccinology and Immunology
St George's, University of London
London
UK
Declarações
KLD declares that their institution has received funds for GBS vaccine clinical trials; she has not received personal funds.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
American Academy of Pediatrics. Group B streptococcal infections. In: Committee on Infectious Diseases, American Academy of Pediatrics, Kimberlin DW, Barnett ED, et al. Red book: 2021-2024 report of the Committee on Infectious Diseases. 32nd ed. Elk Grove Village, IL: AAP; 2021:707-13.
The American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion Summary, Number 797. Obstet Gynecol. 2020 Feb;135(2):489-92.Texto completo Resumo
National Center for Health Statistics. Active bacterial core surveillance (ABCs) report: emerging infections program network - group B streptococcus, 2018 [internet publication].Texto completo
Royal College of Obstetricians and Gynaecologists. The prevention of early onset neonatal group B streptococcal disease. Green-top guideline no. 36. Sep 2017 [internet publication].Texto completo Resumo
Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2014 Jun 10;(6):CD007467.Texto completo Resumo
Puopolo KM, Lynfield R, Cummings JJ, et al. Management of infants at risk for group B streptococcal disease. Pediatrics. 2019 Aug;144(2):e20191881.Texto completo Resumo
American Society for Microbiology. Guidelines for the detection and identification of group B streptococcus. 29 July 2021 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Differentials
- Sepsis caused by other organisms
- Endocarditis caused by other organisms
- Neonatal cytomegalovirus (CMV) infection
More DifferentialsGuidelines
- Guidelines for the detection and identification of group B streptococcus
- Prevention of early-onset group B streptococcal disease in newborns
More GuidelinesPatient information
Cellulitis and erysipelas
Conjunctivitis
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer